# Study to Evaluate Eye Function in Patients Taking Linezolid for Six Weeks or Greater

> **NCT00359632** · PHASE3 · TERMINATED · sponsor: **Pfizer** · enrollment: 34 (actual)

## Conditions studied

- Optic Nerve Diseases

## Interventions

- **DRUG:** Zyvox - linezolid
- **DRUG:** Matched control

## Key facts

- **NCT ID:** NCT00359632
- **Lead sponsor:** Pfizer
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2008-11
- **Primary completion:** 2013-12
- **Final completion:** 2013-12
- **Target enrollment:** 34 (ACTUAL)
- **Why stopped:** Study was stopped due to poor enrollment on 28 Feb 2012. Reason for termination was not due to safety concerns.
- **Last updated:** 2015-06-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00359632

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00359632, "Study to Evaluate Eye Function in Patients Taking Linezolid for Six Weeks or Greater". Retrieved via AI Analytics 2026-07-20 from https://api.ai-analytics.org/clinical/NCT00359632. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*